AnestaGel – A Non-opiate Painkiller Found Superior

InSitu Biologics, LLC (“InSitu” or “the Company”), an emerging drug delivery company focusing on development of new and proprietary treatments using its Matrix™ BioHydrogel, has announced results from recent pre-clinical studies for their lead product, AnestaGel™.

New Drug Might Help Regrow Teeth And End Tooth Fillings Forever

New Drug Might Help Regrow Teeth And End Tooth Fillings Forever, University of Utah Study

More than 86 percent of adults aged 20 to 39 are affected by tooth decay. This means most people have had at least one or two cavities filled in their lifetime, and probably more. A silicone-based cement is used by dentists worldwide to fill holes that remain in teeth when a dentist clears out the infected, decayed part with a drill. These dental fillings for cavities do the job, but wear and tear, as well as hard or chewy foods, can loosen them, increasing the risk of infection and decay.

Fda Takes Steps To Improve Hearing Aid Accessibility

Fda Confirms Elevated Levels of Belladonna in Certain Homeopathic Teething Products

The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label. The agency is warning consumers that homeopathic teething tablets containing belladonna pose an unnecessary risk to infants and children and urges consumers not to use these products.

Study on premature death rates

Researchers Find Premature Death Rates Diverge in The United States

Premature death rates have declined in the United States among Hispanics, blacks, and Asian/Pacific Islanders (APIs) — in line with trends in Canada and the United Kingdom — but increased among whites and American Indian/Alaska Natives (AI/ANs), according to a comprehensive study of premature death rates for the entire U.S. population from 1999 to 2014.

R35 Research Program Award

R35 Research Program Award to Encourage Creative Research

The first 30 recipients of the new R35 Research Program Award (RPA), a pilot program designed to encourage creative research by enhancing funding stability, have been announced by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.